HYEX (Healthy Extracts) Beneish M-Score: -0.27 (As of Jul. 06, 2026)


HYEX Healthy Extracts Inc HYEX
54 GF Score
Price $1.61
GF Value $1.64
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Healthy Extracts Beneish M-Score?

Healthy Extracts HYEX 54 Beneish M-Score is -0.27 as of Jul. 06, 2026. GuruFocus rates HYEX with a GF Score™ of 54/100 and a GF Value™ of $1.64 (Fairly Valued). The stock has 2 warning signs investors should review. Among 910 Drug Manufacturers companies, Healthy Extracts ranks worse than 93.96% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Warning Sign:

Beneish M-Score -0.27 higher than -1.78, which implies that the company might have manipulated its financial results.

The historical rank and industry rank for Healthy Extracts's Beneish M-Score or its related term are showing as below:

HYEX' s Beneish M-Score Range Over the Past 10 Years
Min: -82.99   Med: -4.32   Max: 35.18
Current: -0.27

During the past 12 years, the highest Beneish M-Score of Healthy Extracts was 35.18. The lowest was -82.99. And the median was -4.32.


Healthy Extracts Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Healthy Extracts's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Healthy Extracts Beneish M-Score Chart

Healthy Extracts Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.93 -3.55 -7.17 -3.98 8.58

Healthy Extracts Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -15.40 -3.34 14.26 8.58 -0.27

HYEX vs ZYBT, MRMD, RMTI: Beneish M-Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Healthy Extracts's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Healthy Extracts Beneish M-Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Healthy Extracts's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Healthy Extracts's Beneish M-Score falls into.


HYEX
54GF Score
Healthy Extracts Inc HYEX
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Healthy Extracts Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Healthy Extracts for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 2.3448+0.528 * 0.9987+0.404 * 2.618+0.892 * 1.5475+0.115 * -0.1522
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.2424+4.679 * -0.059885-0.327 * 0.1227
=-0.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was $0.25 Mil.
Revenue was 1.611 + 1.694 + 0.918 + 0.969 = $5.19 Mil.
Gross Profit was 0.989 + 0.957 + 0.447 + 0.593 = $2.99 Mil.
Total Current Assets was $1.09 Mil.
Total Assets was $27.32 Mil.
Property, Plant and Equipment(Net PPE) was $4.55 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.16 Mil.
Selling, General, & Admin. Expense(SGA) was $4.15 Mil.
Total Current Liabilities was $1.59 Mil.
Long-Term Debt & Capital Lease Obligation was $1.68 Mil.
Net Income was -0.201 + -0.154 + -0.395 + 0.067 = $-0.68 Mil.
Non Operating Income was 0.213 + 0.206 + 0.121 + 0.202 = $0.74 Mil.
Cash Flow from Operations was 0.106 + 0.368 + -0.28 + 0.017 = $0.21 Mil.
Total Receivables was $0.07 Mil.
Revenue was 0.931 + 0.771 + 0.745 + 0.908 = $3.36 Mil.
Gross Profit was 0.425 + 0.414 + 0.602 + 0.486 = $1.93 Mil.
Total Current Assets was $1.48 Mil.
Total Assets was $2.41 Mil.
Property, Plant and Equipment(Net PPE) was $0.20 Mil.
Depreciation, Depletion and Amortization(DDA) was $-0.00 Mil.
Selling, General, & Admin. Expense(SGA) was $2.16 Mil.
Total Current Liabilities was $2.35 Mil.
Long-Term Debt & Capital Lease Obligation was $0.00 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(0.254 / 5.192) / (0.07 / 3.355)
=0.048921 / 0.020864
=2.3448

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(1.927 / 3.355) / (2.986 / 5.192)
=0.574367 / 0.575116
=0.9987

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (1.088 + 4.546) / 27.319) / (1 - (1.481 + 0.199) / 2.411)
=0.79377 / 0.303194
=2.618

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=5.192 / 3.355
=1.5475

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(-0.001 / (-0.001 + 0.199)) / (0.156 / (0.156 + 4.546))
=-0.005051 / 0.033177
=-0.1522

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(4.149 / 5.192) / (2.158 / 3.355)
=0.799114 / 0.643219
=1.2424

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((1.683 + 1.585) / 27.319) / ((0 + 2.351) / 2.411)
=0.119624 / 0.975114
=0.1227

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-0.683 - 0.742 - 0.211) / 27.319
=-0.059885

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Healthy Extracts has a M-score of -0.27 signals that the company is likely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -0.27 mean?
Healthy Extracts (HYEX) has a Beneish M-Score of -0.27 as of Jul. 06, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Healthy Extracts and its competitors. According to the industry distribution chart, Healthy Extracts ranks #855 out of 910 companies in the Drug Manufacturers industry, placing it in the top 94%.
Is Healthy Extracts' Beneish M-Score too high?
Healthy Extracts' current Beneish M-Score is -0.27. Based on the distribution chart, Healthy Extracts ranks #855 out of 910 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Healthy Extracts has a GF Score™ of 54/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Healthy Extracts' Beneish M-Score compare to ZYBT and MRMD?
According to the Drug Manufacturers industry distribution chart, Healthy Extracts ranks #855 out of 910 companies for Beneish M-Score. This places Healthy Extracts in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Drug Manufacturers company?
A good Beneish M-Score depends on the Drug Manufacturers industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Healthy Extracts and its competitors. Healthy Extracts's current Beneish M-Score is -0.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Healthy Extracts stock overvalued right now?
Based on GuruFocus' analysis, Healthy Extracts (HYEX) is currently considered Fairly Valued. The stock's GF Value™ is $1.64, compared to a current price of $1.61 — trading 1.8% below its estimated fair value. The current Beneish M-Score is -0.27. Healthy Extracts' overall GF Score™ is 54/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Healthy Extracts (HYEX), the current Beneish M-Score is -0.27 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Healthy Extracts (HYEX) Overvalued in 2026?

Based on GuruFocus' analysis, Healthy Extracts stock appears to be undervalued. The current stock price of $1.61 is trading 1.8% below its estimated GF Value™ of $1.64. GuruFocus considers Healthy Extracts to be Fairly Valued.

Key valuation signals for HYEX:

  • Beneish M-Score: -0.27
  • GF Value™: $1.64 vs. price of $1.61 (1.8% below fair value)
  • GF Score™: 54/100 with 2 warning signs

No single metric tells the full story. See the HYEX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Healthy Extracts Business Description

Address 7375 Commercial Way, Suite 125, Henderson, NV, USA, 89011
Healthy Extracts Inc through its subsidiaries is engaged in proprietary research and development of natural plant-based formulations, manufacturing, sales, and distribution of cardiovascular and neuro products that provide natural brain solutions. The company also provides superfruit supplements to support overall cholesterol, metabolic and cardiovascular health. Its products are distributed in the United States and Mexico. Its operating segment includes, Health Supplements and Corporate. The company generates maximum revenue from the Health Supplements segment.
54GF Score

Get the complete analysis for HYEX

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.61
Price
$1.64
GF Value